Urology under scrutiny: Navigating litigation from missed diagnosis to delayed care

Urological litigation is frequently rooted in diagnostic delay, delayed treatment and failures in systems that should close the loop around investigations and follow-up. A National Health Service claims analysis reported 4124 urology claims from 2006–2007 to 2022–2023; 61% resulted in payment and £145 million in damages. This short review translates those patterns into practical clinical safeguards. Time-critical presentations such as suspected testicular torsion and infected obstruction require escalation pathways that privilege definitive action over serial reassurance. Incidental imaging, haematuria and prostate-cancer pathways need explicit ownership of results and of the next clinical step. The medicolegal test is not a promise of a perfect outcome: it concerns reasonable care, material-risk dialogue and whether any breach caused avoidable harm. Reliable design – named ownership, tracked actions, senior review, contemporaneous records and candid response after harm – offers the most credible route to safer care and fewer defensible claims.